SPARING CYSTECTOMY IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY BLADDER
https://doi.org/10.17650/1726-9776-2009-5-1-27-31
Abstract
Objective: to study the results of sparing cystectomy in patients with urinary bladder cancer (UBC).
Subjects and methods. The study has covered 82 patients with transitional-cell UBC (T1-4aN0M0) who received radiotherapy (RT) and thenunderwent radical cystectomy at the N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, in 1980 to2007. Among them there were 76 (92.7%) males and 6 (7.3%) females. The median age was 55.2±10.8 years. Superficial (T1) and inva-sive (Т2—4а) carcinomas were detected in 33 (40.2%) and 49 (59.8%) patients, respectively. Category N+ was identified in 3 (3.7%) patients.All the patients received RT to the bladder area (median total focal dose (TFD) 56±12.3 Gy) and regional metastatic zones (median TFD40.0±0.0 Gy). A full effect of irradiation was achieved in 44 (53.7%) patients, of whom 41 (93.2%) developed local relapses. All the 82patients underwent radical cystectomy: that with ureterostomy in 28 (34.1%) cases, Bricker’s operation in 45 (54.4%), Studer’s operationin 4 (4.9%), and rectal urinary bladder in 5 (6.1%). The median follow-up was 32.7±31.9 months.
Results. The median interval between RT and cystectomy was 12.5±5.1 months; the median time of surgery was 360 (60—480) min; themedian blood loss was 1515.2±1227.8 ml. Intraoperative and postoperative complications developed in 10 (12.2%) and 40 (48.6%)patients, respectively. Repeated operations were performed in 7 (8.4%) cases. Mortality was 4.9%. A urinary derivation technique failed toaffect the incidence of complications and the rates of mortality (p > 0.05). Histological studies revealed transitional-cell carcinoma in thedistant specimens in 80 (97.6%) cases. Recurrences developed in 40 (48.8%) of the 82 patients following an average of 32.9 (1—150)months of cystectomy: local relapses in 5 (6.1%) cases; distant metastases in 29 (35.4%); a local relapse and distant metastases in 5 (6.1%);urethral recurrence in 1 (1.2%) patient. Five-year overall, specific, and relapse-free survivals were 43.9 (median 48.4±10.5 months), 48.5(59.9±9.3 months), and 42.8% (47.4±9.6 months), respectively.
Conclusion. Sparing cystectomy with any urinary derivation technique is associated with the acceptable frequency of complications and pro-vides fair long-term results in patients who show no complete effect or who have a local UBC relapse after RT.
About the Authors
V. B. Matveyev
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. I. Volkova
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
K. M. Figurin
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. V. Peters
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Cooke P.W., Dunn J.A., Latief T. et al.Long-term risk of salvage cystectomy afterradiotherapy for muscle-invasive bladdercancer. Eur Urol 2000;38(3,):279—86.
2. Swanson D.A., von Eschenbach A.C.,Bracken R. Bruce et al. Salvage cystectomyfor bladder carcinoma. Cancer1981;47(1):2275—9.
3. Edsmyr F., Moberger G., Wadstrom L.Carcinoma of the bladder. Cystectomy aftersupervoltage therapy. Scund J UrolNephrol 1971:5:21—221.
4. Hecker G.N., Hodges C.V., Moore R.J.,Higgens R. Radical cystectomy after super-voltage radiotherapy. J Urol 1964;91:256—60.
5. Higgins P.M., Hamilton R.W., Hope-Stone H.F. The hazards of total cys-tectomy after supervoltage irradiation of thebladder. Br J Urol 1966;38:311—8.
6. Whitmore W.F. Jr., Grabstald H.,Mackenzie A.R. et al. Preoperative irradia-tion with cystectomy in the management ofbladder cancer. Am J Roentgenol1968;102:570—6.
7. Матвеев В.Б., Матвеев Б.П., Фигурин К.М., Волкова М.И. Цистэктомия при инвазивном раке мочевого пузыря. В кн.: Диагностика и лечение рака мочевого пузыря. IV Международный симпозиум. Тезисы докладов. 9—10 июня 2005 г. Нижний Новгород. с. 63.
8. Schuster T.G., Marcovich R., Sheffield J. et al. Radical cystectomy forbladder cancer after definitive prostate can-cer treatment. Urology 2003;61:342—7.
9. Nieuwenhuijzen J.А., Horenblas S.,Meinhardt W. et al. Salvage cystectomyafter failure of interstitial radiotherapy andexternal beam radiotherapy for bladdercancer. BJU Intern 2004;94(6):793—7.
10. Hendry W.F. Morbidity and mortalityof radical cystectomy (1971—78 and1978—1985). J Royal Soc Med1986;79:395—400.
11. Jenkins B.J., Caulfield M.J., Fowler C.G. et al. Reappraisal of the roleof radical radiotherapy and salvage cystec-tomy in the treatment of invasive (T2/T3)bladder cancer. Br J Urol 1988;62:343—6.
12. Lindell O. Salvage cystectomy. Reviewof 19 cases. Eur Urol 1987;13:17—21.
13. Borgaonkar S., Jain A., Bollina P. et al.Radical radiotherapy and salvage cystecto-my as the primary management of transi-tional cell carcinoma of the bladder.Results following the introduction of a CTplanning technique. Clin Oncol (R CollRadiol) 2002;14:141—7.
14. Rodel C., Grabenbauer G.G., Kuhn R. et al. Combined-modality treat-ment and selective organ preservation ininvasive bladder cancer: long-term results. JClin Oncol 2002;20:3061—71.
15. Hayter C.R., Paszat L.F., Groome P.A.et al. A population-based study of the useand outcome of radical radiotherapy forinvasive bladder cancer. Int J Radiat OncolBiol Phys 1999;45:1239—45.
Review
For citations:
Matveyev V.B., Volkova M.I., Figurin K.M., Peters M.V. SPARING CYSTECTOMY IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY BLADDER. Cancer Urology. 2009;5(1):27-31. (In Russ.) https://doi.org/10.17650/1726-9776-2009-5-1-27-31
Views:
1187
Email this article 